PepGen (PEPG)
1.38
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 PepGen Inc. For: May 21 Filed by: Kasraian Kasra
May 26, 2026 4:44 PM - SEC Filing
Form EFFECT PepGen Inc.
May 22, 2026 6:03 AM - SEC Filing
Form 8-K PepGen Inc. For: May 21
May 21, 2026 7:30 AM - SEC Filing
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program
May 21, 2026 7:00 AM - BizWire
H.C. Wainwright Reiterates Buy Rating on PepGen Inc. (PEPG)
May 21, 2026 6:40 AM - StreetInsider
Form S-3 PepGen Inc.
May 19, 2026 12:04 PM - SEC Filing
Form SCHEDULE 13G/A PepGen Inc. Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2026 5:51 PM - SEC Filing
Form SCHEDULE 13G/A PepGen Inc. Filed by: Commodore Capital LP
May 15, 2026 4:28 PM - SEC Filing
PepGen Inc. (PEPG) PT Lowered to $4 at Wedbush
May 13, 2026 8:33 AM - StreetInsider
PepGen Inc. (PEPG) Tops Q1 EPS by 3c
May 12, 2026 5:53 PM - StreetInsider
Form 8-K PepGen Inc. For: May 12
May 12, 2026 4:10 PM - SEC Filing
Form 10-Q PepGen Inc. For: Mar 31
May 12, 2026 4:06 PM - SEC Filing
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 12, 2026 4:05 PM - BizWire
Form ARS PepGen Inc. For: Dec 31
April 28, 2026 4:10 PM - SEC Filing
Form DEFA14A PepGen Inc.
April 28, 2026 4:08 PM - SEC Filing
Form DEF 14A PepGen Inc. For: Jun 18
April 28, 2026 4:06 PM - SEC Filing
Form 8-K PepGen Inc. For: Mar 30
March 30, 2026 5:33 PM - SEC Filing
PepGen reports mixed results from phase 2 DM1 drug trial
March 30, 2026 4:05 PM - StreetInsider
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
March 30, 2026 4:05 PM - BizWire
PepGen (PEPG) halted, news pending
March 30, 2026 4:04 PM - StreetInsider
Full Article List
